Who is sponsoring NCT04873076?

NCT04873076 is sponsored by University Hospital, Essen.

What drugs are being tested in NCT04873076?

Interventions in NCT04873076: Audiovisual distraction using 2d video glasses from HappyMed GmbH.

What condition does NCT04873076 study?

NCT04873076 studies Rhythm; Disorder.

Is NCT04873076 still recruiting?

NCT04873076 is currently completed. Last updated 5 May 2021.

Last reviewed 2021-05-05 · How we verify

NCT04873076

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Audiovisuell Distraction Via 2d Videoglasses During Catheter Ablation Procedures in Cardiac Rhythm Disorders.

Completed NA Last updated 5 May 2021

What this trial tests

NA trial testing Audiovisual distraction using 2d video glasses from HappyMed GmbH in Rhythm; Disorder in 70 participants. Completed in 14 March 2020.

Timeline

20 November 2019

Primary endpoint
13 March 2020

14 March 2020

Quick facts

Lead sponsor	University Hospital, Essen
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	supportive care
Enrollment	70
Start date	20 November 2019
Primary completion	13 March 2020
Estimated completion	14 March 2020
Sites	1 location across Germany

Drugs / interventions tested

Audiovisual distraction using 2d video glasses from HappyMed GmbH

Conditions studied

Rhythm; Disorder — all drugs for Rhythm; Disorder →

Sponsor

University Hospital, Essen

Who can join

18 and older, any sex, with Rhythm; Disorder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In this randomized controlled trial, amount of sedation exposure and patient satisfaction is evaluated in patients undergoing catheter ablation for rhythm disorders via an audiovisual distraction. Patients are randomized into intervention group (adiovisual distraction) or controll (no intervention).

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other University Hospital, Essen trials

Trials by the same sponsor.

NCT07409584 — Mental Health and Suicidality in Glioblastoma Patients in Germany · recruiting
NCT07359690 — Multimodal Analysis of Endomyocardial Biopsies · recruiting
NCT06388369 — Neoadjuvant Lu-PSMA Radioligand Therapy and Ipilimumab in Men With Very High-risk Prostate Cancer · Phase 1, PHASE2 · terminated
NCT07130526 — Distrupt Stiffness Trial · NA · recruiting
NCT07343466 — Quality of Life and the Influence of Stress on the Postoperative Course of Patients After Device Implantation · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04873076 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University Hospital, Essen
Last refreshed: 5 May 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04873076.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing